πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569683

UspA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569386

Chondroitin synthase gene and methods of making and using same

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7566447

Biocides

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7557096

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7556942

Tumor suppressor designated Hippo

The Board of Regents of the University of Texas System Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7550617

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7550141

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7547759

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7547686

Combretastatin A-3 prodrug

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7541346

Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7541429

Comparative ligand mapping from MHC positive cells

The Board of Regents of the University of Oklahoma Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7538129

Diazonamide A analog

The Board of Regents of the University of Texas System Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7528133

Use of thiazolidinediones derivatives for preventing uterine contractions in premature lab

The Board of Regents of the University of Texas System Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7524490

Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a card

The Board of Regents of the University of Texas System Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7521535

Anti-microbial defensin-related peptides and methods of use

The Board of Regents for Oklahoma State University Β· Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7517895

Synthetic diazonamides

The Board of Regents of the University of Texas System Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7514095

Fabrication of drug loaded biodegradable polymer fibers

The Board of Regents of the University of Texas System Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7511124

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral age

The Board of Regents of the University of Texas System Β· Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7507716

Method for treating pain with prolactin antagonists

The Board of Regents of the University of Texas System Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7507556

Nucleic acids encoding rat hyaluronan receptor for endocytosis

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7507422

Urinary tract tissue graft compositions and methods for producing same

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7504435

Method for stimulating weight loss and/or for lowering triglycerides in patients

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted